Before the Beginning: How Medicine Captures Women Before Pregnancy Starts (Part 5)
From Fertility Apps to Prenatal Vitamins: 13 More Interventions That Turn Conception into a Medical Event
This series began with twenty-two interventions in Part 1 and has grown through Parts 2, 3, and 4 to document seventy-one medical intrusions into pregnancy, birth, and early childhood. Each installment revealed new layers of unnecessary medicalization—new ways the system manufactures pathology from normal variation, extracts profit from fear, and positions itself as essential to processes that worked without it for millennia. But a gap remained. The earlier parts assumed pregnancy had already begun. They missed something critical: the system doesn’t wait for conception. It captures women long before the first positive test.
These thirteen interventions fill that gap, tracing the medical colonization of reproduction from its earliest stages. The hormonal birth control that depletes nutrients and masks conditions, setting up fertility problems years before a woman tries to conceive. The fertility tracking apps that promise empowerment but deliver surveillance, selling intimate data while funneling users toward treatment. The preconception “optimization” protocols that find deficiencies in everyone, consuming months of fertile time with testing and supplementation. The egg freezing marketed as insurance but functioning as expensive false hope. The IVF industry that profits from the problems earlier interventions helped create.
What makes these pre-conception and early pregnancy interventions particularly effective is their framing as empowerment. Track your fertility. Optimize your health. Freeze your eggs. Take control. The language of autonomy masks the transfer of authority—from women’s bodies to apps, algorithms, clinics, and protocols. You’re not being controlled; you’re being helped. You’re not being captured; you’re being prepared. The system learned that coercion creates resistance. Empowerment marketing creates compliance.
Fertility treatment is a $30 billion global industry and growing. Egg freezing costs tens of thousands with no guarantee of return. Prenatal vitamins generate billions annually selling synthetic nutrients to women who could get them from food. The screening tests, the specialist consultations, the “optimization” supplements—each extracts payment for services of questionable value, justified by fear of suboptimal outcomes. The woman who conceives easily, carries normally, and births without complication represents lost revenue. The system is not designed to produce her.
The thirteen interventions documented here—from hormonal birth control’s legacy effects through the prenatal vitamin industry—complete the picture that Parts 1 through 4 began. The medical capture of reproduction doesn’t start at the first prenatal appointment. It starts years earlier, when a teenage girl swallows her first birth control pill, when a woman downloads her first fertility app, when someone suggests she might want to freeze her eggs “just in case.” By the time she’s pregnant, she’s been a patient so long she can’t remember what it felt like to trust her body without verification.
The system that will manage her pregnancy, intervene in her labor, and monitor her newborn has been preparing for her arrival since before she decided to conceive. These interventions are the welcome committee—ensuring that by the time she reaches the birth interventions documented in earlier parts, she’ll accept them as normal, necessary, and inevitable.
They aren’t. None of this was inevitable. Understanding how the capture begins is the first step toward refusing it.
Support Independent Research
This work remains free because paid subscribers make it possible. If you find value here, consider joining them.
What paid subscribers get: Access to the Deep Dive Audio Library — 170+ in-depth discussions (30-50 min each) exploring the books behind these essays. New discussions added weekly. That’s 100+ hours of content for less than the price of a single audiobook.
[Upgrade to Paid – $5/month or $50/year]
Get in touch Essay ideas, stories, or expertise to share: unbekoming@outlook.com
Intervention 72: Hormonal Birth Control Legacy Effects
You took the pill for fifteen years. Or the shot, the implant, the hormonal IUD. “Regulating your cycle,” they called it, though what they really meant was overriding it entirely. Synthetic hormones suppressing ovulation month after month, year after year, your body’s own rhythm silenced so completely you forgot it existed. Then you stopped, ready to conceive, and discovered your body had forgotten too.
The nutrient depletion is documented but rarely discussed. Hormonal contraceptives drain B vitamins—B6, B12, folate—the very nutrients critical for early fetal development. They deplete zinc, essential for hormone production and egg quality. Magnesium, selenium, vitamin C—all diminished by years of synthetic hormone exposure. You stop the pill already deficient in what pregnancy demands most. Nobody mentions this when they hand you the prescription at sixteen. Nobody suggests replenishing before you try to conceive at thirty-two.
The return to ovulation isn’t instant. “Post-pill amenorrhea” sounds clinical, almost theoretical, until you’re tracking cycles that don’t come, watching apps predict ovulation that doesn’t happen. For some women, normal cycles return within weeks. Others wait months, sometimes longer, while their hypothalamic-pituitary-ovarian axis remembers how to function without pharmaceutical direction. The research says most women return to baseline fertility eventually. But “eventually” doesn’t feel reassuring when you’re thirty-five and every cycle matters.
The pill masks underlying conditions. Endometriosis, PCOS, premature ovarian insufficiency—all hidden beneath artificial bleeds that aren’t real periods, synthetic regularity that isn’t real health. You think your cycles are normal because the pill makes them appear normal. Then you stop and discover your body was struggling all along, only you didn’t know because the medication hid the evidence for a decade.
Cervical mucus—the substance that guides sperm to egg—takes time to normalize after years of hormonal suppression. The pill thickens it to prevent conception; that thickening doesn’t reverse overnight. Some women never regain the quality of fertile mucus they would have had without intervention.
Research suggests the gut microbiome shifts on hormonal contraception, affecting nutrient absorption, inflammation, hormone metabolism. The vaginal microbiome changes too—alterations that may influence conception and early pregnancy viability. You’re not just stopping a pill; you’re trying to restore systems that were systematically disrupted.
And when conception doesn’t happen quickly? The fertility clinic is waiting. The same medical system that handed you synthetic hormones at sixteen is ready to sell you synthetic hormones at thirty-six—only now they’re injectable, monitored, exponentially more expensive. The pill that was supposed to give you control has delivered you, depleted and desperate, to reproductive endocrinologists who will medicalize what should have been natural.
Nobody studies what would have happened if you’d never taken it. Nobody tracks the women who used fertility awareness instead, who knew their bodies’ patterns, who came to conception with full nutrient stores and functioning axes. Those women don’t generate fertility clinic revenue.
The birth control you took for years wasn’t neutral. It extracted payment that comes due when you want to conceive. The “freedom” it offered was a loan—payable in depleted nutrients, suppressed function, and appointments with specialists for problems that might never have existed.
Intervention 73: Fertility Tracking Apps
You stopped the pill and downloaded an app. Seemed logical—your body’s signals were unfamiliar after years of suppression, and here was technology promising to decode them. Enter your period dates, your basal temperature, your cervical mucus observations. The algorithm will tell you when you’re fertile. The algorithm will notify you when to have sex. The algorithm knows your body better than you do.
Except it doesn’t. These apps predict ovulation based on averages, assumptions, past patterns projected forward. But ovulation isn’t predictable—it responds to stress, sleep, travel, illness, nutrition. The app says you’re fertile on day 14 because that’s the textbook average. Your body, still recalibrating after years of synthetic hormones, might ovulate on day 19. Or day 22. Or not at all this cycle. You have sex when the app tells you, miss your actual fertile window entirely, and conclude something is wrong with you rather than with the algorithm.
The anxiety manufacture is elegant. Every cycle becomes a performance review. The app tracks your “timing score,” tells you whether you hit the fertile window, calculates your statistical odds of conception. You’re not making love; you’re executing a protocol. The spontaneity that might actually support conception—relaxation, connection, oxytocin—gets replaced by scheduled intercourse and performance pressure. Some couples describe their sex life becoming clinical within months of app-directed trying.
The data entry becomes obsessive. Temperature taken before moving, before speaking, at exactly the same time daily. Cervical mucus checked multiple times, categorized, logged. Every symptom scrutinized for meaning. You’re becoming a technician of your own body rather than an inhabitant of it. The app needs data; you provide it compulsively, anxiously, losing trust in sensation that isn’t quantified.
When cycles don’t conform to predictions, the apps offer explanations that pathologize. “Irregular cycles detected.” “Possible anovulatory cycle.” “Consider consulting a fertility specialist.” The referral pipeline is built into the interface. Three months of irregular predictions and the app is suggesting you might have a problem, might need help, might need to escalate. Some apps partner with fertility clinics, building referral pathways into the interface.
The privacy extraction runs parallel to the anxiety. Your menstrual data, sexual activity, pregnancy attempts—sold to advertisers, data brokers, potentially insurers. You’ve handed intimate biological information to corporations whose interests aren’t your fertility but your monetization.
The cruelest part is what the apps displace. Fertility awareness methods—real ones, taught by educators, learned over months—give women genuine body literacy. You learn to read cervical mucus directly, to feel ovulation pain, to recognize your own patterns without algorithmic interpretation. This knowledge is free, private, accurate when properly learned. But it requires patience, education, trust in your body’s signals. The app promises instant expertise, no learning curve, certainty delivered via notification.
Women who abandon apps and learn actual fertility awareness describe revelation. Their bodies were communicating all along—temperature shifts, mucus changes, cervical position. The signals were there. The app was just noise overlaying signal, algorithmic guesses drowning out biological clarity.
The technology that promised to help you conceive may be doing the opposite: creating anxiety that delays conception, directing sex to wrong days, pathologizing normal variation, and funneling you toward interventions when patience and body literacy might have been enough.
Your body knows when it’s fertile. It’s been broadcasting that information for months. The app is just too loud for you to hear it.
Intervention 74: Preconception “Optimization” Protocols
You walked in healthy. You’ll walk out with a supplement protocol, a follow-up appointment, and the first flickers of doubt that your body can do this without management.
The apps said your cycles were irregular. The forums said you should “optimize” before trying. So now you’re sitting in a clinic you didn’t know existed six months ago, getting blood drawn for a panel testing things you’ve never heard of. AMH, FSH, estradiol, thyroid antibodies, vitamin D, ferritin, homocysteine, MTHFR mutations.
The preconception industry barely existed twenty years ago. Now it’s a growth sector—supplements, testing panels, consultations, programs. “Optimize your fertility.” “Prepare your body for pregnancy.” “Give your baby the best start.” The language implies your body in its natural state is suboptimal, unprepared, offering something less than best. You need products and professionals to elevate it to adequacy.
The testing panels find something in everyone. Vitamin D below the ever-rising “optimal” threshold. Ferritin in the “suboptimal” range. A MTHFR variant that half the population carries. Thyroid antibodies present but not yet causing dysfunction. Each result becomes a problem to solve, a supplement to take, a reason to delay conception until your numbers improve. You came in ready to conceive. Now you’re told to wait while you optimize.
The supplement stacks multiply. Prenatal vitamins, obviously. But also CoQ10 for egg quality. Omega-3s for inflammation. Vitamin D to reach optimal levels. Methylfolate because of that MTHFR variant. NAC for glutathione support. Myo-inositol for ovarian function. Suddenly you’re spending hundreds monthly on pills to prepare for a pregnancy that hasn’t happened, for problems that may not exist, based on tests interpreted by people who profit from finding abnormalities.
The genetic screening adds another layer. Carrier screening for hundreds of conditions before you’ve even conceived—identifying whether you and your partner might, in combination, produce a child with a rare disorder. The probability math is dizzying. You’re both carriers for something affecting 1 in 40,000 births? That’s a 1 in 4 chance if both carriers, but you’re talking about a condition you’d never heard of, that might be manageable, that your child statistically won’t have. But now you know. And you can’t unknow it.
The “fertility nutritionists” and “preconception coaches” have multiplied alongside the anxiety. They’ll review your test results, design your protocol, adjust your supplements quarterly. They’re not doctors, but they speak with authority about optimizing your terrain, reducing inflammation, supporting mitochondrial function. Each consultation reinforces that conception is complicated, technical, requiring expertise you lack.
Men get pulled in too now. Sperm analysis, hormone panels, supplement protocols for motility and morphology. The message is consistent: your bodies as they are cannot be trusted to do what bodies have done without intervention for three hundred thousand years.
The delay is the hidden cost. Months spent optimizing, retesting, adjusting protocols. For women already anxious about age, the optimization phase consumes fertile time while promising to improve fertility. The thirty-four-year-old who might have conceived immediately spends eight months getting her ferritin up, her vitamin D optimized, her supplement stack perfected. She’s thirty-five before she starts trying. Now she’s Advanced Maternal Age, and a new cascade begins.
Some women emerge from optimization protocols more anxious than when they entered. They’ve learned to see their bodies as collections of suboptimal lab values. Conception, when it happens, doesn’t end the vigilance—it intensifies it. The optimization mindset carries forward: now they need the right prenatal protocol, the right testing schedule, the right managed pregnancy.
Women who skip optimization—who simply stop contraception and start trying—mostly conceive without incident. Their babies are healthy. They never learned their MTHFR status or their AMH level or their vitamin D number. They didn’t need to. Their bodies, unoptimized, did what bodies do.
The system profits from the uncertainty it manufactures. You weren’t a patient before you wanted a baby. Now you are, and you’ll remain one—through conception, pregnancy, birth, and beyond. The optimization was never about preparing your body. It was about preparing you to be managed.
Intervention 75: Egg Freezing Marketing
You’re thirty-two and single, or partnered but not ready, or focused on career, or just not there yet. And everywhere—billboards, Instagram ads, workplace benefits presentations—the message arrives: freeze your eggs. Take control. Stop your biological clock. Empower yourself. The language is liberation, autonomy, choice. The reality is a $15,000 gamble marketed as insurance, selling false security to women taught to fear their own bodies.
The pitch is elegant. Your fertility is declining. Every year you wait, your egg quality drops. But technology offers a solution—harvest your eggs now, freeze them, use them later when you’re ready. You’re not delaying motherhood; you’re preserving options. The clinic billboards show confident women, briefcases in hand, smiling at their frozen future. What they don’t show is the fine print.
The numbers they don’t emphasize: egg freezing isn’t banking babies. It’s banking probability, and the odds are worse than the marketing suggests. Of eggs frozen, roughly 80-90% survive thawing. Of those, perhaps 70-80% fertilize. Of embryos created, maybe 30-50% implant. Work the math backward: a woman freezing ten eggs at thirty-four might have a 50-60% chance of one live birth from those eggs. Not the “insurance policy” the brochures implied. More like a coin flip that cost more than a used car.
The age paradox is cruel. The younger you freeze, the better your eggs—but the less likely you are to need them. The older you freeze, the more urgently you feel you need them—but the lower the quality and quantity retrieved. Women who freeze at thirty-eight, desperate to beat the clock, often retrieve few eggs of diminished quality. The procedure they hoped would extend their fertility window mostly confirmed it was already closing.
The process itself is IVF without the embryo. Two weeks of hormone injections, bloating, mood swings, ovarian hyperstimulation risk. Repeated monitoring appointments, transvaginal ultrasounds, blood draws. Then egg retrieval under sedation—a needle through the vaginal wall into each ovary, aspirating follicles. It’s not a lunch-break procedure. It’s a medical event with real risks: infection, bleeding, ovarian torsion, hyperstimulation syndrome severe enough to require hospitalization.
The costs extend beyond the initial cycle. Retrieval runs $10,000-15,000. Medications add thousands more. Annual storage fees—$500-1,000—accumulate indefinitely. Then, if you use them, you’re paying for IVF: thawing, fertilization, transfer, another $15,000-20,000. The “investment” in future fertility can exceed $50,000 before you know if it worked.
Corporate America discovered egg freezing as a benefit around 2014. Apple, Google, Facebook—suddenly offering to pay for employees to freeze eggs. Framed as progressive, supporting women’s careers. The unspoken message: delay children for us, we’ll help you preserve the option. The company gets your prime working years without the inconvenience of parental leave. You get eggs in a freezer you may never use.
Most women never use their frozen eggs. Studies suggest relatively few—perhaps 10-20%—return to thaw them. Some conceive naturally. Some never try. Some can’t afford the IVF required to use them. The eggs sit in liquid nitrogen, annual storage fees charged to credit cards, an insurance policy against a future that arrived differently than planned.
The women who do return often face disappointment. The eggs that were supposed to be twenty-nine-year-old eggs are still twenty-nine-year-old eggs—but the uterus they’re going into is thirty-nine. Success rates depend on both. And when the frozen eggs fail, when multiple cycles yield nothing, the grief is compounded by years of false security. They thought they had a backup plan. They had frozen cells and marketing copy.
Nobody markets the alternative: that fertility extends longer than panic suggests for many women, that conception at thirty-eight or forty happens daily without intervention, that the anxiety driving the egg freezing industry is itself partly manufactured by the industry profiting from it.
Your eggs in a freezer aren’t freedom. They’re a holding pattern—expensive, uncertain, maintained by companies that profit whether you use them or not. The empowerment was always theirs. They sold you fear of your own biology, then sold you the solution.
Intervention 76: IVF and Fertility Treatment Cascade
The optimization failed. The frozen eggs weren’t enough. The apps couldn’t find a fertile window that worked. Or maybe you just couldn’t conceive after a year of trying, and now you’re sitting in a reproductive endocrinologist’s office hearing words like “unexplained infertility” and “assisted reproductive technology.” You walked in hoping for answers. You’ll walk out with a protocol, a medication calendar, and a credit card charge that could buy a car.
IVF—in vitro fertilization—is presented as the solution. The miracle technology that creates babies when bodies can’t. What they emphasize less: it works about 30-50% of the time for women under thirty-five, dropping to 10-20% by forty, and nearly single digits beyond that. You’re not buying a baby. You’re buying chances, and each chance costs $15,000-20,000, medications included.
The process colonizes your body completely. First comes downregulation—drugs to shut down your natural cycle so they can control everything. Then ovarian stimulation—daily injections of synthetic hormones to force your ovaries to produce not one egg but ten, fifteen, twenty. Your ovaries swell to the size of grapefruits. You’re bloated, emotional, exhausted, driving to the clinic every other day for ultrasounds and blood draws to monitor the harvest.
Ovarian hyperstimulation syndrome—OHSS—is the risk they mention quickly. Mild cases affect perhaps a quarter of women: bloating, discomfort, nausea. Severe cases—affecting 1-2%—mean hospitalization, fluid accumulating in your abdomen and lungs, ovaries so swollen they can twist on their stalks. Women have died from OHSS. The forms mention this. The marketing doesn’t.
Egg retrieval happens under sedation. A needle through the vaginal wall, guided by ultrasound, puncturing each follicle, aspirating the contents. You wake up cramping, bleeding, hoping the number they tell you is high enough. Twelve eggs retrieved. But how many mature? Nine. How many fertilize? Six. How many make it to day five? Three. The attrition is relentless, each morning call from the lab a verdict on which embryos survived the night.
Then comes grading. Your embryos ranked like cuts of meat—AA, AB, BB, BC. The embryologist explains morphology, fragmentation, cell division rates. You’re staring at microscope images of your potential children, being told which ones look “good” and which are “fair.” Conception has become quality control, your offspring scored before they’ve implanted.
The transfer is anticlimactic after all that. A catheter through the cervix, embryos deposited, and then you wait. Two weeks of progesterone injections, of analyzing every twinge for meaning, of trying not to test too early. The blood draw comes. Positive means more monitoring, more ultrasounds, more anxiety. Negative means deciding whether you can afford, emotionally and financially, to do it again.
Multiple embryo transfers created the IVF multiples boom. Twins, triplets, sometimes more—pregnancies the human body wasn’t designed to carry efficiently. These multiples arrive preterm at alarming rates, filling NICUs, requiring interventions their singleton counterparts wouldn’t need. Recent shifts toward single embryo transfer have helped, but many clinics still transfer two or three, chasing success rates that look better when twins count as “pregnancy achieved.”
The IVF pregnancy, when it happens, enters the medical system already labeled. “ART conception”—assisted reproductive technology—goes in your chart. You’re high-risk by definition now. More monitoring, more ultrasounds, more testing. The pregnancy achieved through intervention requires more intervention to maintain. The cascade that started with birth control continues unbroken.
The emotional extraction parallels the financial. Hope sold and sold again, each failed cycle reframed as “information.” The sunk cost fallacy takes hold—you’ve already spent $30,000, how can you stop now? Some couples spend six figures, emptying retirement accounts, borrowing from parents, all for a chance that might never come.
Women who conceived naturally after abandoning IVF describe the irony. Bodies that wouldn’t cooperate under surveillance relaxed once the protocols stopped. Conception that eluded pharmaceutical control happened spontaneously, quietly, the way it was supposed to.
The fertility industry is worth tens of billions globally and growing. Every woman who struggles to conceive—whether from birth control legacy effects, age-related panic, optimization delays, or genuine pathology—represents revenue. The system that may have contributed to her infertility stands ready to sell her the solution.
Conception evolved outside laboratories. Sometimes intervention is genuinely necessary. But an industry built on hope, desperation, and imperfect odds has every incentive to expand its market—to label more women infertile sooner, to recommend treatment faster, to keep the cycles coming until the money or the marriage runs out.
Intervention 77: Advanced Maternal Age (AMA) Labeling
You turn thirty-five during pregnancy and everything changes. Not your body—your body is the same as it was at thirty-four years and eleven months. But your chart now carries a label: Advanced Maternal Age. Some systems still use the older term: geriatric pregnancy. You’re not geriatric. You might run marathons, have perfect bloodwork, feel stronger than you did at twenty-five. Doesn’t matter. The label is attached, and the label drives everything that follows.
The cutoff is arbitrary, rooted in decades-old calculations that had nothing to do with overall pregnancy risk. In the 1970s, researchers determined that at age thirty-five, the risk of having a baby with Down syndrome roughly equaled the risk of miscarriage from amniocentesis. That statistical crossover point—relevant only to one specific decision about one specific test—became the bright line separating “normal” from “high-risk.” A number chosen for amniocentesis counseling now dictates the management of every aspect of your pregnancy.
The moment the label attaches, the testing cascade begins. Additional ultrasounds. Cell-free DNA screening pushed earlier and harder. Nuchal translucency measurements scrutinized. Recommendations for amniocentesis or CVS that wouldn’t have been made at thirty-four. Each test carries its own anxiety, its own false positive rates, its own potential for findings that lead to more testing. You entered pregnancy healthy. The label has made you a diagnostic project.
The monitoring intensifies as pregnancy progresses. Non-stress tests in the third trimester, sometimes twice weekly. Biophysical profiles checking amniotic fluid, fetal movement, breathing practice. Growth scans looking for restriction or excess. Each appointment another opportunity to find something concerning, to justify intervention. Women without the label don’t get this surveillance. Their babies aren’t monitored into emergencies.
The induction pressure builds as your due date approaches. “We don’t like to let AMA mothers go past thirty-nine weeks.” “The placenta ages faster after thirty-five.” “The risk of stillbirth increases.” The language is designed to frighten, and it works. Never mind that the absolute risk increase is small. Never mind that induction itself carries risks. Never mind that your placenta doesn’t know how old you are. The label has determined your management, and your management is early delivery whether your body is ready or not.
Cesarean rates for AMA mothers exceed those for younger women, and research suggests this isn’t entirely explained by medical complications. Some of the difference is genuine—older mothers do have slightly higher rates of certain complications. But much of it is the label creating its own outcomes. The provider who sees “AMA” in the chart has a lower threshold for intervention. The labor that would be given more time in a twenty-eight-year-old gets diagnosed as “failure to progress” in a thirty-six-year-old. The heart rate tracing that would be watched in a younger woman triggers cesarean in an older one. The label shapes perception, perception shapes decisions, decisions shape outcomes.
The psychological burden is real but unmeasured. You’re treated as fragile, declining, working against time. Every appointment reinforces that your body is less capable than it was, that your pregnancy is more dangerous than it should be. The confidence that might carry you through labor—the trust in your body’s ability—erodes under constant surveillance and risk language. By delivery, you’ve absorbed the message: you’re too old for this to go well on its own.
The IVF connection tightens the loop. Women who conceived through assisted reproduction are often older—the fertility delays, the optimization protocols, the treatment cycles consumed years. Now they’re pregnant, finally, and immediately labeled high-risk for their age. The pregnancy achieved through intervention requires more intervention to maintain. AMA plus ART conception plus the anxiety of hard-won pregnancy equals maximum medical management.
The research tells a more nuanced story than the protocols suggest. Yes, certain risks increase with maternal age—chromosomal abnormalities, gestational diabetes, hypertension. But healthy thirty-eight-year-olds without these complications don’t benefit from being treated as sick. The blanket label captures millions of women whose only risk factor is a birthday, subjecting them to interventions designed for genuinely complicated pregnancies.
Other countries handle this differently. The UK uses “older mother” and individualizes care based on actual health status, not age alone. Some European systems don’t apply automatic protocols at thirty-five, instead assessing each woman’s specific situation. Their outcomes aren’t worse. Their cesarean rates are lower. Their mothers aren’t terrorized by a label.
Women who refuse the AMA cascade—who decline the extra testing, who push back on early induction, who insist on being treated as healthy unless proven otherwise—often have uncomplicated pregnancies and births. Their bodies, unlabeled, do what bodies do. The risk was never in their age. It was in the label, and everything the label justified.
You’re not geriatric. You’re not advanced. You’re a pregnant woman whose age crossed an arbitrary threshold invented for a different purpose fifty years ago. The label doesn’t describe your body. It describes how they’ve decided to manage you.
Intervention 78: Routine Pelvic Exams During Pregnancy
Your first prenatal appointment arrives, and before you’ve finished answering questions about your last period, you’re in a gown, feet in stirrups, someone’s fingers inside you. “Just a quick exam,” they say, as if the invasion is minor, as if your body being entered is unremarkable. You’re six weeks pregnant, nauseated, possibly bleeding slightly, terrified of loss—and your introduction to prenatal care is a stranger’s hand in your vagina.
The routine pelvic exam in early pregnancy has little clinical justification for most women. A bimanual exam—fingers inside, hand pressing on abdomen—supposedly assesses uterine size and position. But ultrasound does this better, without penetration, without discomfort. The exam supposedly screens for abnormalities. But if you had your last Pap smear on schedule, there’s nothing to screen for. The exam supposedly establishes a “baseline.” A baseline for what? Your vagina doesn’t change in ways that require manual tracking.
What the exam does establish is precedent. Your body is now medical territory. Access has been granted, boundaries redefined. The provider who just examined you internally will do so again and again—cervical checks, membrane sweeps, labor assessments. Each subsequent intrusion will feel more normal because the first one happened so easily, so routinely, before you’d thought to question it.
The infection risk is not theoretical. Every vaginal exam introduces bacteria toward the cervix. In early pregnancy, when the cervix is closed and the mucus plug is forming, this matters less. But the pattern normalizes exams throughout pregnancy, including later when each check increases ascending infection risk. The exam at eight weeks trains compliance for the exam at thirty-eight weeks—the one that might introduce bacteria that cause the chorioamnionitis that justifies the emergency cesarean.
The discomfort is dismissed, minimized, treated as your problem. The speculum is cold. The bimanual pressure is uncomfortable at best, painful at worst. You might be tensing because you’re anxious, or because your body is correctly signaling that it doesn’t want to be penetrated. “Try to relax,” they say, as if tension is a failing rather than a response. The message: your discomfort is inconvenient, your resistance is the problem, your body’s signals should be overridden.
For women with trauma histories, these exams can be devastating. Sexual assault survivors may experience routine pelvic exams as re-traumatization. The positioning—supine, legs spread, someone between them, penetration happening—echoes violation. Some women dissociate. Some avoid prenatal care entirely. The routine exam that “everyone gets” becomes a barrier to care for those who need support most.
The frequency varies by practice but rarely by medical indication. Some providers examine internally at every visit. Others at the first visit, then again in the third trimester, then weekly until delivery. The schedule reflects habit, training, billing opportunity—not evidence. Studies don’t support routine pelvic exams improving pregnancy outcomes. ACOG’s own guidelines don’t mandate them for low-risk women with current cervical screening. Yet the exams continue, appointment after appointment, because that’s how it’s done.
The cascade feeds forward. The woman examined routinely throughout pregnancy accepts the cervical check at thirty-six weeks without question. She accepts the membrane sweep at thirty-nine weeks because declining seems difficult after so many prior exams. She accepts the multiple vaginal exams during labor—sometimes by different providers, sometimes without warning—because her body stopped feeling like her own months ago. The boundary erosion was gradual, systematic, complete.
Other countries find this excessive. In the Netherlands, midwives don’t routinely perform vaginal exams during pregnancy unless clinically indicated. In the UK, NICE guidelines don’t recommend routine pelvic exams for low-risk pregnancies. Their maternal outcomes aren’t worse. Their women aren’t under-examined. They simply don’t penetrate pregnant women without reason.
Women who decline routine pelvic exams—who request they only be performed when clinically necessary, who maintain their boundaries throughout pregnancy—often describe feeling more in control during labor. Their bodies remained theirs. The pattern of compliance wasn’t established. When labor came, they were prepared to question interventions because they’d been questioning them all along.
The exam isn’t routine because it’s necessary. It’s routine because someone decided it would be, and no one questioned whether it should be. Your pregnant body isn’t public property. Access isn’t automatic. The gown and stirrups don’t suspend your right to ask: Why? What will this tell you? What changes if we don’t do it?
The answer, often, is nothing. Nothing changes except your experience of pregnancy as something done to you rather than something you’re doing.
Intervention 79: Prenatal Mental Health Screening → SSRI Prescribing
The questionnaire arrives at your first prenatal visit. “Over the past two weeks, how often have you felt down, depressed, or hopeless?” You’re six weeks pregnant, exhausted, nauseated every waking moment, terrified something will go wrong because you’ve read the miscarriage statistics. You check “several days.” A few more questions about sleep, appetite, energy—all disrupted by the pregnancy itself—and your score triggers a conversation. “Have you considered medication for depression?”
The Edinburgh Postnatal Depression Scale and similar screening tools were designed to catch severe, debilitating depression that might otherwise go unnoticed. Reasonable goal. But deployed as universal screening at every prenatal visit, they capture something else entirely: the normal emotional landscape of pregnancy. Anxiety about the future. Grief over the life you’re leaving behind. Fear of loss, of pain, of inadequacy. Hormonal shifts that create mood instability. The screening doesn’t distinguish between clinical depression and the emotional weight of growing a human. It just generates scores.
Scores generate diagnoses. Diagnoses generate prescriptions. The pathway from screening questionnaire to SSRI prescription can be remarkably short—sometimes the same appointment. The provider sees the score, asks a few follow-up questions, reaches for the prescription pad. Sertraline, the go-to for pregnancy. “It’s the safest option,” they say, as if any psychotropic medication crossing the placenta is safe, as if we have long-term data on children exposed in utero, as if “safest” means safe rather than “least studied risks.”
The risks are real but minimized. SSRIs in pregnancy correlate with increased miscarriage risk in some studies, though the picture is complicated—depression itself may increase miscarriage risk, making causation difficult to establish. Later in pregnancy, SSRI exposure correlates with preterm birth, low birth weight, and persistent pulmonary hypertension of the newborn (PPHN), a serious respiratory condition. Neonatal adaptation syndrome affects up to 30% of exposed newborns—jitteriness, respiratory distress, feeding difficulties, sometimes seizures. These aren’t rare side effects. They’re common enough that NICUs recognize the pattern.
The long-term effects on children remain insufficiently studied. Research shows associations between prenatal SSRI exposure and increased rates of autism spectrum disorder, ADHD, anxiety, and depression in offspring—though whether medication or underlying maternal mental health drives these associations remains unclear. The studies are observational, confounded by the conditions being treated. But “we don’t know” should prompt caution, not dismissal. Instead, the uncertainty becomes permission to prescribe: we can’t prove it’s harmful, so we’ll assume it’s fine.
The screening itself shapes what it measures. A woman who might have described herself as “adjusting to pregnancy” before the questionnaire now has a depression score. The number reframes her experience. Maybe she is depressed. Maybe she should be worried. The seed is planted. At subsequent visits, she’s asked again. Her awareness of being monitored for depression can create the hypervigilance that elevates her scores. The screening doesn’t just detect—it produces.
Alternative interventions exist but aren’t offered with equal enthusiasm. Therapy—particularly cognitive behavioral therapy—shows comparable efficacy to medication for mild to moderate depression, without fetal exposure. Support groups connect pregnant women experiencing similar struggles. Exercise, when possible, improves mood. Addressing practical stressors—financial pressure, relationship conflict, inadequate support—might resolve what presents as depression. But these interventions require time, access, resources. A prescription takes thirty seconds.
The women who genuinely need medication—those with severe, pre-existing depression, those at risk of self-harm, those unable to function—are not the problem. Medication may be necessary and appropriate for them. The problem is the universal screening that sweeps in everyone else: the mildly anxious, the appropriately overwhelmed, the hormonally destabilized, the sad. They receive the same intervention as the severely ill because the screening doesn’t differentiate, and the system has one primary solution.
The framing makes refusal difficult. “We want to make sure you’re okay.” “Depression can affect your baby’s development.” “Untreated depression is risky too.” The implication: if you decline medication, you’re gambling with your baby’s wellbeing. Never mind that mild depression might resolve with support, that medication carries its own risks to the baby, that you might prefer to try other approaches first. The pharmaceutical solution is positioned as the responsible choice.
Women who decline SSRIs during pregnancy, who pursue therapy or support or watchful waiting instead, often find their symptoms manageable. Their babies aren’t exposed to psychotropic medication during critical development windows. Some struggle and eventually choose medication—and that choice, made after trying alternatives, is different from the reflexive prescription at the first elevated score.
The questionnaire isn’t asking about your mental health. It’s sorting you into a treatment pathway. Your normal pregnancy emotions—the fear, the ambivalence, the grief, the overwhelm—become symptoms requiring pharmaceutical management. The screening that claims to help may be creating patients out of women who needed support, not medication.
Your sadness might be appropriate. Your anxiety might be rational. Your mood swings might be hormonal. None of these are necessarily depression. None of them necessarily require medication that crosses to your baby.
But the score says what it says, and the prescription is already being written.
Intervention 80: Amniocentesis and CVS
The screening test came back “elevated risk.” Maybe 1 in 150 for Down syndrome, maybe a soft marker on ultrasound—an echogenic bowel, a slightly short femur. Now they’re recommending definitive testing. Amniocentesis or CVS. A needle through your abdomen into your uterus, extracting fluid or tissue from around your baby. The only way to know for certain, they say. What they don’t emphasize: the procedure itself can end the pregnancy you’re trying to protect.
Amniocentesis carries a miscarriage risk of roughly 1 in 300 to 1 in 500 at experienced centers—lower than historically quoted, but not zero. CVS, performed earlier, carries similar or slightly higher risk. These numbers sound small until you’re the one miscarrying a wanted pregnancy after an elective procedure. The baby you lost might have been chromosomally normal. You’ll never know. The test that was supposed to provide answers instead provided tragedy.
The funnel toward these procedures starts with screening. Cell-free DNA tests, quad screens, nuchal translucency measurements—all generating risk ratios that sound precise but aren’t diagnoses. A 1 in 100 risk means 99 out of 100 babies don’t have the condition. But that number, printed on paper, labeled “high risk,” creates pressure. The only way to resolve the uncertainty is invasive testing. The screening industry feeds the diagnostic procedure industry.
False positives from screening drive unnecessary amniocentesis. A woman with a 1 in 50 screen result has a 98% chance her baby is unaffected. But she doesn’t feel that 98%. She feels the fear, the uncertainty, the need to know. So she consents to the needle. Most women who undergo amnio after positive screening discover their babies are fine. They endured the procedure, the anxiety, the miscarriage risk, for reassurance they might not have needed.
The waiting is its own torture. Two weeks for full results, sometimes longer. You’re visibly pregnant, feeling movement, bonding despite yourself—while waiting to learn if your baby has a condition that might change everything. The limbo state affects the pregnancy itself. Stress hormones, disrupted sleep, ambivalent attachment. The test doesn’t just sample cells; it samples your capacity to cope.
When results are positive, the counseling tilts toward termination. Statistics about life expectancy, medical complications, developmental delays. Rarely do genetic counselors bring in families living with these conditions, adults with Down syndrome holding jobs and relationships, the full spectrum of what these diagnoses actually mean. The information is selectively curated toward a particular decision. Your “choice” is shaped by what they choose to tell you.
Some conditions detected are genuinely severe—fatal in infancy, incompatible with any quality of life. But many aren’t. Down syndrome, Turner syndrome, XXY—people with these conditions live full lives. The tests can’t tell you severity, can’t predict function, can’t show you your specific child’s potential. They deliver a label and leave you to imagine the worst.
Women who decline invasive testing after positive screening often deliver healthy babies. The “high risk” resolved into no risk at all. Others deliver babies with chromosomal differences and find the reality manageable, even joyful. The testing promised certainty but delivered only a different kind of uncertainty—the question of what you would have done had you known, whether knowing served you at all.
The needle offers answers. It also offers loss—of pregnancy, of peace, of the ability to meet your baby without a diagnosis preceding them.
Intervention 81: Tdap Vaccination During Pregnancy
Somewhere around 28 weeks, they recommend the Tdap vaccine. Tetanus, diphtheria, pertussis—the last one is the sell. “Whooping cough can be fatal in newborns,” they explain. “The antibodies will cross the placenta and protect your baby until they can be vaccinated.” It sounds reasonable. What they don’t mention: you’ll be injected with aluminum adjuvant during the third trimester, when your baby’s brain is in a critical growth phase.
The aluminum is the issue. Tdap contains aluminum salts as adjuvants—compounds that provoke stronger immune response. Aluminum is a known neurotoxin. The question isn’t whether aluminum is harmful to developing brains; it’s whether the amount in vaccines, delivered intramuscularly, reaches the fetus in meaningful quantities. The studies that would answer this definitively haven’t been done. The recommendation proceeds anyway.
The antibody transfer argument has limits. Yes, maternal antibodies cross the placenta. But those antibodies wane quickly—by two months, protection has dropped significantly. The baby still needs their own vaccines on schedule to maintain protection. The maternal dose buys a narrow window, not comprehensive immunity. Meanwhile, pertussis in newborns, while serious, is rare. The absolute risk reduction from maternal vaccination is small because the baseline risk is small.
The timing raises questions. The recommendation is for every pregnancy, regardless of when you last received Tdap. A woman with pregnancies two years apart gets two doses in two years. The aluminum accumulates. The immune activation repeats. No studies examine the effects of multiple closely-spaced doses during multiple pregnancies. The recommendation assumes safety without establishing it.
The fever risk matters. Tdap causes fever in some recipients. Fever in pregnancy correlates with increased risk of preterm labor and, depending on timing and severity, potential developmental effects. The package insert acknowledges fever as a common side effect. The recommendation doesn’t weigh this risk against pertussis prevention. It assumes the tradeoff favors vaccination without quantifying either side.
The pertussis narrative deserves scrutiny. Outbreaks occur in highly vaccinated populations. The vaccine’s effectiveness wanes faster than previously understood—protection drops significantly within a few years. Vaccinated individuals can still carry and transmit pertussis asymptomatically. The maternal vaccine may provide some passive immunity to newborns, but it’s not the firewall it’s marketed as. The disease is presented as imminent threat; the vaccine is presented as reliable shield. Neither framing is entirely accurate.
Cocooning was the previous strategy—vaccinating everyone around the newborn rather than the pregnant woman. It fell out of favor not because it failed but because compliance was difficult. Maternal vaccination is easier to enforce: one patient, one appointment, one injection. The strategy shifted for logistical convenience, not superior evidence.
Women who decline Tdap during pregnancy aren’t leaving their babies defenseless. They’re choosing to avoid aluminum and immune activation during fetal brain development. They may vaccinate postpartum, or focus on limiting newborn exposure during the vulnerable weeks. These aren’t irrational choices. They’re risk calculations the medical system doesn’t acknowledge as legitimate.
The injection is quick. The aluminum stays longer. The studies that would tell you what that means for your baby’s developing brain don’t exist.
Intervention 82: Steroid Injections for Threatened Preterm Birth
You’re 28 weeks and something’s wrong—contractions, shortened cervix, maybe your water broke early. The diagnosis is threatened preterm labor, and suddenly you’re getting steroid injections. Betamethasone, two doses 24 hours apart. “To mature the baby’s lungs,” they explain. “In case delivery happens.” The steroids will help your baby breathe if born early. What they don’t emphasize: the steroids affect far more than lungs, and the “threat” of preterm birth often doesn’t materialize.
The lung maturation benefit is real—for babies actually born preterm within seven days of administration. Steroids accelerate surfactant production, reducing respiratory distress syndrome. This is genuine, evidence-based benefit for genuinely premature babies. The problem is prediction. Distinguishing true preterm labor from false alarms is notoriously difficult. Many women given steroids for “threatened” preterm birth deliver at term. Their babies got the drugs but didn’t need the benefit.
The steroid effects extend beyond lungs. These are powerful hormones crossing the placenta, reaching the fetal brain during critical development. Animal studies show lasting effects on brain structure and stress-response systems from prenatal steroid exposure. Human studies are harder to conduct but raise concerns: children exposed to antenatal steroids show subtle differences in behavior, attention, and stress reactivity. The brain wasn’t the target, but the brain got dosed.
The repeat course problem compounds the risk. When preterm birth doesn’t happen after the first steroid course, but the “threat” continues, some providers give additional courses. “Rescue” doses, they call them. Each course adds exposure. Studies on repeat steroids show diminishing benefit and accumulating concerns—reduced fetal growth, smaller head circumference, potential neurodevelopmental effects. The intervention that helps once may harm when repeated.
The threshold for administration keeps dropping. Originally reserved for imminent preterm delivery, steroids now get given for shortened cervix on ultrasound, for contractions that might be nothing, for “just in case” scenarios where the probability of preterm birth is low. The risk-benefit calculation assumes high probability of early delivery. When that probability is actually modest, the calculation shifts—but the steroids get given anyway.
The cascade is familiar. Something looks concerning on monitoring. Intervention is offered. Declining feels like gambling with your baby’s life. You accept. The preterm birth never happens. Your full-term baby was exposed to powerful steroids that crossed into their developing brain. No one follows up to assess whether that exposure mattered. The intervention is charted as appropriate. The question of whether it was necessary never gets asked.
Women who question steroid timing—who ask about the actual probability of preterm delivery, who request watchful waiting when signs are ambiguous—sometimes avoid unnecessary exposure. Their term babies weren’t subjected to lung maturation drugs they didn’t need. But questioning requires confidence, information, and a provider willing to engage. Most women simply receive the injection and hope it was the right call.
The steroids might save your preterm baby’s life. They might also affect your term baby’s brain. Knowing which scenario you’re in is the part they can’t reliably tell you.
Intervention 83: Home Fetal Dopplers
The device arrives from Amazon, sleek and reassuring. A home fetal doppler, so you can hear your baby’s heartbeat whenever anxiety strikes. The reviews are glowing—peace of mind, bonding experience, hearing that galloping rhythm at 3 AM when worry won’t let you sleep. What the reviews don’t mention: this device might kill your baby by convincing you everything is fine when it isn’t.
The problem is interpretation. Finding a heartbeat sounds simple. It isn’t. The untrained ear can mistake maternal pulse for fetal heartbeat, placental blood flow for baby’s heart, the whooshing of your own aorta for signs of life. The sounds overlap, confuse, deceive. A mother who “heard the heartbeat” this morning may have heard herself. Meanwhile, her baby—in genuine distress or already gone—received no medical attention because the doppler provided false reassurance.
The FDA and professional medical organizations warn against home doppler use for exactly this reason. Case reports document stillbirths where mothers delayed seeking care because they believed they’d detected heartbeat at home. The device that promised peace of mind delivered the opposite—a false sense of security that prevented timely intervention. The kicks had slowed, something felt wrong, but the doppler said otherwise. The doppler was wrong.
Even when the device does find the actual fetal heartbeat, rate alone tells you little. A baby in distress might have a normal heart rate. A baby with a cord compression might have a heart rate that dips only during movement or contractions—patterns a snapshot listening session would miss. Medical monitoring is continuous, interpreted, contextual. Home doppler use is none of these. You’re hearing a number without understanding what it means.
The anxiety loop is real. Women who buy dopplers for reassurance often find the opposite. Can’t find the heartbeat? Panic. Baby moved and now you lost the sound? Terror. The device creates dependency—checking daily, then twice daily, then whenever worry surfaces. Each session is a small test your baby might fail. The pregnancy becomes an endless series of pass/fail moments instead of a continuous unfolding.
The false reassurance cuts both ways. Reduced fetal movement is a critical warning sign. When babies move less, it can indicate distress. The appropriate response is medical evaluation. But a mother with a doppler might check the heartbeat, hear something, and stay home. The movement reduction—the actual signal—gets overridden by the doppler’s apparent reassurance. The baby needed monitoring. The baby got a consumer device.
The marketing sells empowerment. Know your baby is okay without waiting for appointments. Bond with your baby by hearing their heart. Take control of your pregnancy. The language of autonomy and connection masks what the device actually does: it transfers medical monitoring to untrained hands, removes professional interpretation, and creates opportunities for catastrophic misreading.
Midwives and doctors use dopplers in clinical settings because they’re trained to find, identify, and interpret what they hear. They know the difference between maternal and fetal sounds. They understand what rate variations mean. They use dopplers as one tool among many, not as standalone reassurance. The same device in untrained hands isn’t the same device at all.
Your anxiety is real. Your desire to know your baby is okay is natural. The home doppler promises to satisfy both. What it actually delivers is a false sense of competence in a domain where competence requires training. The kicks your baby gives you are better information than any consumer device. Trust them first.
Intervention 84: Prenatal Vitamin Industry
Before you’ve even confirmed the pregnancy, someone’s told you to start prenatals. The pharmacy aisle overwhelms—gummies, capsules, organic, prescription-strength, with DHA, without DHA. Prices range from eight dollars to eighty. The packaging shows glowing pregnant women, promises of optimal fetal development, the unspoken threat: without this pill, you might harm your baby. A multi-billion dollar industry built on the fear that your diet isn’t enough.
The folic acid story is the foundation. Neural tube defects—spina bifida, anencephaly—can be prevented by adequate folate, they claim. This became the wedge that opened the market. If one vitamin prevents one defect, imagine what a pill with thirty ingredients might do. The specific claim, repeated enough times, became assumed truth. The industry built an empire on that assumption, expanding far beyond anything the original studies examined.
The expansion has little evidence behind it. Most prenatal vitamin ingredients—the alphabet of vitamins, the parade of minerals—haven’t been shown to improve pregnancy outcomes in well-nourished women. Iron supplementation helps women who are genuinely deficient; it constipates everyone else. Calcium matters if you don’t consume dairy; it’s redundant if you do. DHA sounds essential until you learn that eating fish twice weekly provides more than any capsule. The kitchen does what the pill promises to do.
The synthetic problem runs deep. Prenatal vitamins contain isolated, laboratory-created compounds—molecules that resemble nutrients but aren’t packaged the way food packages them. Vitamins in food come with cofactors, enzymes, companion nutrients that affect absorption and utilization. A vitamin C molecule from an orange arrives with bioflavonoids; ascorbic acid from a factory arrives alone. The body may not treat them the same way. The assumption that synthetic equals natural is an assumption, not a fact.
The quality control issues are alarming. Supplements aren’t regulated like drugs. Testing by independent labs routinely finds prenatals that don’t contain what they claim, contain contaminants including heavy metals, or have doses different from labels. The thirty-dollar “premium” prenatal and the eight-dollar store brand may have more in common than their prices suggest—both may be unreliable. You’re trusting your baby’s development to an unregulated industry with documented quality problems.
The marketing creates pressure that serves no one’s health. Women who eat well feel guilty for not adding pills. Women who can’t afford expensive supplements feel they’re shortchanging their babies. The messaging implies that pregnancy requires pharmaceutical support—that food isn’t enough, that bodies can’t be trusted, that optimal development comes from capsules, not plates. The industry profits from undermining confidence in ordinary nutrition.
Traditional cultures grew healthy babies without prenatal vitamins. They ate nutrient-dense foods—liver, fish, fermented vegetables, bone broths. The nutrients came packaged with cofactors that enhanced absorption, in forms bodies recognized. The supplement industry isolated these nutrients, synthesized them, compressed them into pills, and sold them back as essential. Food became insufficient by marketing, not by biology.
Your body has grown babies on real food for three hundred thousand years. The prenatal vitamin industry is fifty years old. The assumption that you need their products to do what your ancestors did without them serves their revenue, not your baby.
These thirteen interventions prepare the ground. By the time a woman arrives at the hospital in labor, she’s been a patient for months or years—tracked, tested, optimized, labeled. The interventions documented in Part 6 await her there: the labor management, the delivery protocols, the immediate postpartum procedures. She’s been trained to accept them. The capture that began before conception reaches its full expression in the birth suite.
Support Independent Research
This work remains free because paid subscribers make it possible. If you find value here, consider joining them.
What paid subscribers get: Access to the Deep Dive Audio Library — 170+ in-depth discussions (30-50 min each) exploring the books behind these essays. New discussions added weekly. That’s 100+ hours of content for less than the price of a single audiobook.
[Upgrade to Paid – $5/month or $50/year]
Get in touch Essay ideas, stories, or expertise to share: unbekoming@outlook.com
New Biology Clinic
For those of you looking for practitioners who actually understand terrain medicine and the principles we explore here, I want to share something valuable. Dr. Tom Cowan—whose books and podcasts have shaped much of my own thinking about health—has created the New Biology Clinic, a virtual practice staffed by wellness specialists who operate from the same foundational understanding. This isn’t about symptom suppression or the conventional model. It’s about personalized guidance rooted in how living systems actually work. The clinic offers individual and family memberships that include not just private consults, but group sessions covering movement, nutrition, breathwork, biofield tuning, and more. Everything is virtual, making it accessible wherever you are. If you’ve been searching for practitioners who won’t look at you blankly when you mention structured water or the importance of the extracellular matrix, this is worth exploring. Use discount code “Unbekoming” to get $100 off the member activation fee. You can learn more and sign up at newbiologyclinic.com
Thank you for this amazing article. I have a very pregnant friend who needs this, and another friend wanting to conceive again. I will forward this VERY important message to them.
Oddly enough...Follow the Money...